Immune cell profiling to guide therapeutic decisions in rheumatic diseases

Nature Reviews Rheumatology

Volumn 11, Issue 9, 2015, Pages 541-551

  Ermann, Joerg ^a   Rao, Deepak A ^a   Teslovich, Nikola C ^a   Brenner, Michael B ^a   Raychaudhuri, Soumya ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALPHA1 INTEGRIN; BIOLOGICAL MARKER; CD19 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; HLA DRB1 ANTIGEN; INFLIXIMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB; STAT3 PROTEIN; T LYMPHOCYTE RECEPTOR; TETRAMER; TOCILIZUMAB; TRANSCRIPTION FACTOR;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL DECISION MAKING; CYTOMETRY; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; IMMUNE CELL FUNCTION ASSAY; MASS CYTOMETRY; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; B LYMPHOCYTE; CELL CULTURE; GENETIC ASSOCIATION; GENETICS; IMMUNOLOGY; RHEUMATIC DISEASES; T LYMPHOCYTE;

B-LYMPHOCYTES; CELLS, CULTURED; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RHEUMATIC DISEASES; T-LYMPHOCYTES;

EID: 84940602262     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2015.71     Document Type: Review

References (108)

1. Robinson, W. H. et al. Mechanistic biomarkers for clinical decision making in rheumatic diseases. Nat. Rev. Rheumatol. 9, 267-276 (2013).
2. Emery, P. & Dörner, T. Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response. Ann. Rheum. Dis. 70, 2063-2070 (2011).
3. Virgo, P. F. & Gibbs, G. J. Flow cytometry in clinical pathology. Ann. Clin. Biochem. 49, 17-28 (2012).
4. Kittleson, M. M. & Kobashigawa, J. A. Long-Term care of the heart transplant recipient. Curr. Opin. Organ Transplant 19, 515-524 (2014).
5. Mirnezami, R., Nicholson, J. & Darzi, A. Preparing for precision medicine. N. Engl. J. Med. 366, 489-491 (2012).
6. Hollebecque, A., Massard, C., & Soria, J. C. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development. Curr. Opin. Oncol. 26, 340-346 (2014).
7. Sander, B., Andersson, J. & Andersson, U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119, 65-93 (1991).
8. Perez, O. D. & Nolan, G. P. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 20, 155-162 (2002).
9. Wells, A. D., Gudmundsdottir, H. & Turka, L. A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100, 3173-3183 (1997).
10. Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205-1213 (1987).
11. Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291-296 (2012).
12. Pitzalis, C., Kingsley, G., Murphy, J. & Panayi, G. Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin. Immunol. Immunopathol. 45, 252-258 (1987).
13. Ichikawa, Y., Shimizu, H., Yoshida, M. & Arimori, S. Activation antigens expressed on T-cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Clin. Exp. Rheumatol. 8, 243-249 (1990).
14. + T cells as a marker of disease activity in rheumatoid arthritis. Ann. Rheum. Dis. 59, 190-195 (2000).
15. REG balance in patients with rheumatoid arthritis. Rheumatol. Int. 32, 2731-2736 (2012).
16. REG imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 32, 887-893 (2012).
17. REG cells in rheumatoid arthritis: an update. Curr. Rheumatol. Rep. 15, 352 (2013).
18. REG cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum. 64, 2499-2503 (2012).
19. Pesce, B. et al. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clin. Exp. Immunol. 171, 237-242 (2013).
20. Thiolat, A. et al. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol. 66, 273-283 (2014).
21. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C. & Bradfield, C. A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl Acad. Sci. USA 93, 6731-6736 (1996).
22. - T cells in patients with rheumatoid arthritis. Arthritis Res. Ther. 5, R210-R213 (2003).
23. + T cells in severe rheumatoid arthritis. Arthritis Rheum. 40, 1106-1114 (1997).
24. -negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response. J. Rheumatol. 37, 911-916 (2010).
25. -negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis. J. Rheumatol. 38, 2105-2111 (2011).
26. Dass, S. et al. Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis. Arthritis Rheum. 58, 2993-2999 (2008).
27. Brezinschek, H. P., Rainer, F., Brickmann, K. & Graninger, W. B. B lymphocyte-Typing for prediction of clinical response to rituximab. Arthritis Res. Ther. 14, R161 (2012).
28. Sellam, J. et al. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 63, 3692-3701 (2011).
29. Vital, E. M. et al. Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-Treatment. Arthritis Rheum. 62, 1273-1279 (2010).
30. Daien, C. I. et al. High levels of memory B cells are associated with response to a first tumor necrosis factor inhibitor in patients with rheumatoid arthritis in a longitudinal prospective study. Arthritis Res. Ther. 16, R95 (2014).
31. Vital, E. M., Dass, S., Buch, M. H., Rawstron, A. C. & Emery, P. An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204544.
32. Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
33. Snir, O. et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1∗0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 63, 2873-2883 (2011).
34. Scally, S. W. et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210, 2569-2582 (2013).
35. James, E. et al. Citrulline specific TH1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol. 66, 1712-1722 (2014).
36. Franz, B., May, K. F. Jr, Dranoff, G. & Wucherpfennig, K. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood 118, 348-357 (2011).
37. Chattopadhyay, P. K. et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 12, 972-977 (2006).
38. Bendall, S. C., Nolan, G. P., Roederer, M., Chattopadhyay, P. K. A deep profiler's guide to cytometry. Trends Immunol. 33, 323-332 (2012).
39. Maecker, H. T., McCoy, J. P. & Nussenblatt, R. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 12, 191-200 (2012).
40. Newell, E. W. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol. 31, 623-629 (2013).
41. Bodenmiller, B. et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat. Biotechnol. 30, 858-867 (2012).
42. Bendall, S. C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
43. Gaudillière, B. et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci. Transl. Med. 6, 255ra131 (2014).
44. Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
45. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
46. Bennett, L. et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723 (2003).
47. Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl Acad. Sci. USA 100, 2610-2615 (2003).
48. Ermann, J. & Bermas, B. L. The biology behind the new therapies for SLE. Int. J. Clin. Pract. 61, 2113-2119 (2007).
49. Crow, M. K. Type I interferon in the pathogenesis of lupus. J. Immunol. 192, 5459-5468 (2014).
50. Rönnblom, L. & Eloranta, M. L. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol. 25, 248-253 (2013).
51. Burska, A. N. et al. Gene expression analysis in RA: towards personalized medicine. Pharmacogenomics J. 14, 93-106 (2014).
52. Thurlings, R. M. et al. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis Rheum. 62, 3607-3614 (2010).
53. Raterman, H. G. et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res. Ther. 14, R95 (2012).
54. Palmer, C., Diehn, M., Alizadeh, A. A. & Brown, P. O. Cell-Type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 7, 115 (2006).
55. + T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 16, 586-591 (2010).
56. + T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J. Clin. Invest. 121, 4170-4179 (2011).
57. Pratt, A. G. et al. A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease. Ann. Rheum. Dis. 71, 1374-1381 (2012).
58. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).
59. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63 (2009).
60. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).
61. Tang, F. et al. mRNA-Seq whole-Transcriptome analysis of a single cell. Nat. Methods 6, 377-382 (2009).
62. Wu, A. R. et al. Quantitative assessment of single-cell RNA-sequencing methods. Nat. Methods 11, 41-46 (2014).
63. Shalek, A. K. et al. Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature 510, 363-369 (2014).
64. Geiss, G. K. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26, 317-325 (2008).
65. Kulkarni, M. M. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr. Protoc. Mol. Biol. http://dx.doi.org/10.1002/0471142727.mb25b10s94.
66. Janetzki, S. et al. "MIATA"-minimal information about T cell assays. Immunity 31, 527-528 (2009).
67. Britten, C. M. et al. T cell assays and MIATA: the essential minimum for maximum impact. Immunity 37, 1-2 (2012).
68. + memory T cells. J. Exp. Med. 186, 859-865 (1997).
69. Mori, T. et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170, 59-64 (2004).
70. Duffy, D. et al. Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli. Immunity 40, 436-450 (2014).
71. Chen, W. et al. Emerging microfluidic tools for functional cellular immunophenotyping: a new potential paradigm for immune status characterization. Front. Oncol. 3, 98 (2013).
72. Altman, R. B. & Raychaudhuri, S. Whole-genome expression analysis: challenges beyond clustering. Curr. Opin. Struct. Biol. 11, 340-347 (2001).
73. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003).
74. Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
75. Eisen, M. B., Spellman, P. T., Brown. P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998).
76. Raychaudhuri, S., Stuart. J. M. & Altman. R. B. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac. Symp. Biocomput. 2000, 455-466 (2000).
77. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
78. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
79. Kratz, A. & Carninci, P. The devil in the details of RNA-seq. Nat. Biotechnol. 32, 882-884 (2014).
80. Pyne, S. et al. Automated high-dimensional flow cytometric data analysis. Proc. Natl Acad. Sci. USA 106, 8519-8524 (2009).
81. Hu, X. et al. Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells. Proc. Natl Acad. Sci. USA 110, 19030-19035 (2013).
82. Aghaeepour, N. et al. Critical assessment of automated flow cytometry data analysis techniques. Nat. Methods 10, 228-238 (2013).
83. Qiu, P. et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29, 886-891 (2011).
84. Amir, E. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545-552 (2013).
85. Shekhar, K., Brodin, P., Davis, M. M. & Chakraborty, A. K. Automatic Classification of Cellular Expression by Nonlinear Stochastic Embedding (ACCENSE). Proc. Natl Acad. Sci. USA 111, 202-207 (2014).
86. Finck, R. et al. Normalization of mass cytometry data with bead standards. Cytometry A 83, 483-494 (2013).
87. Bruggner, R. V., Bodenmiller, B., Dill, D. L., Tibshirani, R. J. & Nolan, G. P. Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl Acad. Sci. USA 111, E2770-E2777 (2014).
88. Pagès, F. et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353, 2654-2666 (2005).
89. Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964 (2006).
90. Galon, J. et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J. Pathol. 232, 199-209 (2014).
91. Nomura, L., Maino, V. C. & Maecker, H. T. Standardization and optimization of multiparameter intracellular cytokine staining. Cytometry A 73, 984-991 (2008).
92. Singh, P. P., Smith, V. L., Karakousis, P. C. & Schorey, J. S. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J. Immunol. 189, 777-785 (2012).
93. Schett, G., Elewaut, D., McInnes, I. B., Dayer, J. M. & Neurath, M. F. How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat. Med. 19, 822-824 (2013).
94. Hulett, H. R., Bonner, W. A., Barrett, J. & Herzenberg, L. A. Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence. Science 166, 747-749 (1969).
95. Williams, A. F. Galfrè, G. & Milstein, C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell 12, 663-673 (1977).
96. Parks, D. R., Hardy, R. R. & Herzenberg, L. A. Three-color immunofluorescence analysis of mouse B-lymphocyte subpopulations. Cytometry 5, 159-168 (1984).
97. Roederer, M. et al. Heterogeneous calcium flux in peripheral T cell subsets revealed by five-color flow cytometry using log-ratio circuitry. Cytometry 21, 187-196 (1995).
98. De Rosa, S. C., Herzenberg, L. A., Herzenberg, L. A. & Roederer, M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7, 245-248 (2001).
99. Saiki, R. K. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491 (1988).
100. Schena, M., Shalon, D., Davis, R. W. & Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995).
101. Heid, C. A., Stevens, J., Livak, K. J. & Williams, P. M. Real time quantitative PCR. Genome Res. 6, 986-994 (1996).
102. de Hair, M. J. et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 66, 513-522 (2014).
103. Pitzalis, C., Kelly, S. & Humby, F. New learnings on the pathophysiology of RA from synovial biopsies. Curr. Opin. Rheumatol. 25, 334-344 (2013).
104. Zhu, J. et al. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature 497, 494-497 (2013).
105. Schlapbach, C. et al. Human TH9 cells are skin-Tropic and have autocrine and paracrine proinflammatory capacity. Sci. Transl. Med. 6, 219ra8 (2014).
106. - entheseal resident T cells. Nat. Med. 18, 1069-1076 (2012).
107. Gerlag, D. M. & Tak, P. P. How to perform and analyse synovial biopsies. Best Pract. Res. Clin. Rheumatol. 27, 195-207 (2013).
108. Kelly, S. et al. Ultrasound-guided synovial biopsy: a safe, well-Tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann. Rheum. Dis. 74, 611-617 (2015).